Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Nafithromycin

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    India Develops First Indigenous Antibiotic
    India Develops First Indigenous Antibiotic "Nafithromycin"

    18 Oct 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-develops-first-indigenously-discovered-antibiotic-nafithromycin-effective-against-resistant-respiratory-infections/articleshow/124673238.cms

    ECONOMICTIMES
    18 Oct 2025
    Share Share
    MDC Seeks Clarity On Nafithromycin Exemption From DPCO
    MDC Seeks Clarity On Nafithromycin Exemption From DPCO

    30 Sep 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=181567&sid=1

    PHARMABIZ
    30 Sep 2025
    Share Share
    Lancet Regional Health Releases Key Phase 3 Study On Miqnaf
    Lancet Regional Health Releases Key Phase 3 Study On Miqnaf

    26 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/the-lancet-regional-health-publishes-pivotal-phase-3-clinical-study-on-miqnaf-17880

    INDPHARMAPOST
    26 Sep 2025
    Share Share
    CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf
    CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf

    04 Jan 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/cdsco-approves-wockhardts-new-generation-oral-antibiotic-miqnaf-nafithromycin/

    EXPRESSPHARMA
    04 Jan 2025
    Share Share
    Indian Pharma Develops Drug To Combat Antibiotic Resistance
    Indian Pharma Develops Drug To Combat Antibiotic Resistance

    05 Dec 2024

    // BUSINESS STD

    https://www.business-standard.com/health/indian-pharma-develops-more-effective-drug-to-combat-antibiotic-resistance-124120500493_1.html

    BUSINESS STD
    05 Dec 2024
    Share Share
    Soft Launch Of Nafithromycin To Combat AMR AnnounceBy Dr. Jitendra
    Soft Launch Of Nafithromycin To Combat AMR AnnounceBy Dr. Jitendra

    21 Nov 2024

    // EXPRESSPHARMA

    https://www.expresspharma.in/soft-launch-of-first-indigenous-antibiotic-to-combat-amr-nafithromycin-announced-by-dr-jitendra-singh/

    EXPRESSPHARMA
    21 Nov 2024
    Share Share